Literature DB >> 4257896

The effect of a series of anti-cancer drugs on plasma cholinesterase activity.

E K Zsigmond, G Robins.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4257896     DOI： 10.1007/bf03006910

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN： 0008-2856


× No keyword cloud information.
  8 in total

1.  The relation between plasma cholinesterase and prolonged apnea caused by succinylcholine.

Authors:  F F FOLDES; V M FOLDES; J C SMITH; E K ZSIGMOND
Journal:  Anesthesiology       Date:  1963 Mar-Apr       Impact factor: 7.892

2.  Prolonged apnea following succinylcholine in cancer patients receiving AB-132.

Authors:  R I WANG; C A ROSS
Journal:  Anesthesiology       Date:  1963 May-Jun       Impact factor: 7.892

3.  Estimation of succinylcholine blood levels.

Authors:  N KVISSELGAARD; F MOYA
Journal:  Acta Anaesthesiol Scand       Date:  1961       Impact factor: 2.105

4.  Causes and prevention of prolonged apnea with succinylcholine.

Authors:  J H BIRCH; F F FOLDES; L RENDELL-BAKER
Journal:  Curr Res Anesth Analg       Date:  1956 Nov-Dec

5.  Comparison of the respiratory effects of suxamethonium and suxethonium in man.

Authors:  F F FOLDES; M SWERDLOW; E LIPSCHITZ; G R VAN HEES; S P SHANOR
Journal:  Anesthesiology       Date:  1956 Jul-Aug       Impact factor: 7.892

6.  The relation of plasma cholinesterases to response to clinical doses of succinylcholine.

Authors:  Werner Kalow
Journal:  Can J Anaesth       Date:  2008-12       Impact factor: 5.063

7.  Sensitivity to succinylcholine in relation to serum-cholinesterase.

Authors:  F T EVANS; P W S GRAY; H LEHMANN; E SILK
Journal:  Lancet       Date:  1952-06-21       Impact factor: 79.321

8.  [Inhibition of serum cholinesterase by cyclophosphamide (endoxan)].

Authors:  H Wolff
Journal:  Klin Wochenschr       Date:  1965-08-01
  8 in total
  8 in total

Review 1.  Safety considerations in the use of drug combinations during general anaesthesia.

Authors:  E S Ransom; R A Mueller
Journal:  Drug Saf       Date:  1997-02       Impact factor: 5.606

2.  Drop of Butyrylcholinesterase Activity after Cyclophosphamide Conditioning as a Predictive Marker of Liver Transplant-Related Complications and Its Correlation with Transplant-Related Mortality in Pediatric Hematopoietic Stem Cell Recipients.

Authors:  Natalia Maximova; Giulia Caddeo; Davide Zanon; Alessandra Maestro; Roberto Simeone
Journal:  J Clin Med       Date:  2019-06-10       Impact factor: 4.241

Review 3.  A guide to drug interactions in anaesthetic practice.

Authors:  A W Grogono; J L Seltzer
Journal:  Drugs       Date:  1980-04       Impact factor: 9.546

4.  Medical evaluation before operation.

Authors:  D L Elliot; D H Linz; J A Kane
Journal:  West J Med       Date:  1982-10

Review 5.  Cancer, chemotherapy and anaesthesia.

Authors:  F Chung
Journal:  Can Anaesth Soc J       Date:  1982-07

Review 6.  Adverse effects of depolarising neuromuscular blocking agents. Incidence, prevention and management.

Authors:  W J Book; M Abel; J B Eisenkraft
Journal:  Drug Saf       Date:  1994-05       Impact factor: 5.606

7.  Anticancer Chemotherapy and it's Anaesthetic Implications (Current Concepts).

Authors:  R P Gehdoo
Journal:  Indian J Anaesth       Date:  2009-02

Review 8.  Pharmacokinetic drug interactions in anaesthetic practice.

Authors:  M Wood
Journal:  Clin Pharmacokinet       Date:  1991-10       Impact factor: 6.447
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.